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Abstract
Background: Streptococcus pneumoniae (SPn) is an important pathogen causing a variety of clinical manifestations.
The effects of SPn nasopharyngeal colonization on respiratory tract infections are poorly studied. We evaluated the
association of SPn colonization with features of respiratory tract infections.
Methods: Children under the age of 6 years who visited a primary care physician because of respiratory tract
infections were enrolled in the study. History was taken, children were clinically assessed by the physician, and
nasopharyngeal swabs were obtained and cultured for SPn. Positive samples were serotyped. Associations of SPn
colonization with clinical signs and symptoms, recovery duration, absence from day care centre, frequencies of
specific diagnoses, and treatment with antimicrobials were evaluated.
Results: In total 900 children were enrolled. The prevalence of SPn colonization was 40.8 % (n = 367). There were
minor differences between male and female subjects (199 of 492, 40.4 % vs 168 of 408, 41.2 %, p = 0.825). Children
with and without siblings had similar colonization rates (145 of 334, 43.4 % vs 219 of 562, 39.0 %, p = 0.187). Clinical
signs and symptoms were not associated with SPn colonization. Children colonized with SPn had longer recovery
duration compared to non-colonized children (114 of 367, 31.1 % vs 98 of 533, 18.4 %, p < 0.001) and were longer
absent from day care (270 of 608, 44.4 % vs 94 of 284, 33.1 %, p = 0.001). Pneumonia, sinusitis, and acute otitis
media were more frequently diagnosed in children colonized with SPn. Children attending day care centres had
significantly higher prevalence of SPn colonization (270 of 367, 44.4 % vs 338 of 533, 33.1 %, p = 0.001). Children
with pneumonia, sinusitis and acute otitis media were more frequently treated with antimicrobials than children
with other diagnoses.
Conclusions: SPn nasopharyngeal colonization has a negative impact on the course of respiratory tract infection,
likely because of SPn being the cause of the disease or a complicating factor. It is also associated with and may be
responsible for higher frequencies of bronchitis, pneumonia, acute otitis media, sinusitis and the need of
antimicrobial treatment.
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Background
Streptococcus pneumoniae (SPn) is one of the leading
pathogens causing a variety of clinical manifestations es-
pecially among young children. It is responsible for
around 11 % of deaths in children under the age of
5 years worldwide [1]. SPn colonizes the nasopharynx
(NP) [2] and it may be asymptomatic or result in dis-
eases such as upper respiratory tract infection (URTI),
acute otitis media (AOM), sinusitis, pneumonia, sepsis
and meningitis which are a considerable burden [1].
Most of these diseases often require antimicrobial treat-
ment and SPn has shown increasing resistance to anti-
microbials which is another public health concern [3–5].
Many recent studies emphasize the contribution of
SPn to severe diseases such as pneumonia, bacter-
aemia, meningitis [6–12], and AOM [13–17], and the
ability of pneumococcal conjugate vaccines to prevent
them. Our study is somewhat novel in this regard that
we examined the influence of SPn nasopharyngeal
colonization on common respiratory tract infections
(RTI), a cause of which may be SPn. Preschool chil-
dren often present with RTI at their primary care phy-
sicians. Cough, fever, symptoms referable to throat,
and earache are among the 20 leading principal rea-
sons for outpatient visits [18]. The nasopharynx is the
reservoir for SPn and the carriage of SPn in children
with acute RTI has not been studied widely. This study
was undertaken to evaluate the circulation of SPn
serotypes among children under 6 years of age with
acute RTI in Lithuania before the introduction of
universal pneumococcal vaccination in the country in
October 2014 [19]. This paper is an extension to the
other results of our study which were published
separately [20].
The possible associations of SPn nasopharyngeal
colonization with the recovery time during the RTI, clin-
ical signs and symptoms, and treatment with antimicro-
bials were analysed in our study. . Day care centres
(DCC) and young siblings are known risk factors for
SPn colonization [21, 22], and associations of DCC
attendance and young siblings with SPn colonization
were also evaluated.
As we did not test for other pathogens in the naso-
pharynges of our subjects, we could not determine the
aetiology of the disease. We hypothesised that the RTI
of children colonized with SPn (who are at risk of de-
veloping pneumococcal disease) is longer and more
severe than RTI of non-colonized children. Nasopha-
ryngeal colonization with SPn increases one’s risk of
developing pneumococcal disease [23]. The most com-
mon cause of RTI is viral, which may facilitate the
conversion of asymptomatic carriage of SPn to a
pathogen and pneumococcal disease may be more se-
vere than that caused by other pathogens.
Methods
Children presenting with RTI at seven primary care
centres in five major cities in Lithuania (Vilnius, Kau-
nas, Panevezys, Alytus, Klaipeda) and the Emergency
Department of Children’s Hospital, Affiliate of Vilnius
University Hospital Santariskiu Klinikos were included
in our study. Vilnius Regional Biomedical Research
Ethics Committee (Lithuania) approval was obtained
(2011-11-08 No. 158200-11-418-118) and the parents
or legal representatives were asked to sign an informed
consent form before the child was enrolled in the study.
The study was carried out from February 2012 to
March 2013.
All subjects satisfied all of the following criteria at the
study entry:
 Aged 0–71 months old at the day of sampling;
 Visited the primary health care provider (general
practitioner or paediatrician) because of either upper
or lower acute respiratory tract infection (fever of
37.20 C or higher, and/or symptoms of respiratory
tract infection: coryza, sore throat, cough, sneezing);
 Symptoms lasted no longer than 1 week from onset;
Signed by parents or legal representatives of the Pa-
tient Informed Consent and Written Agreement to par-
ticipate in the study form. Subjects applying for any of
the exclusion criteria listed below were not included in
the study:
 Another known cause of fever is identified (e.g.
confirmed infection other than RTI, such as urinary
tract infection, etc.);
 History of vaccination with any pneumococcal
vaccine (because of the vaccine’s effect on reducing
colonization with vaccine serotypes [24]);
 Pre-treatment with antimicrobials for current RTI or
treatment with antimicrobials within one month
prior the enrolment, so as not to diminish the yield
of nasopharyngeal culture samples.
General information, demographic data (date of birth,
date of examination, siblings aged less than 6 years,
DCC attendance, and prior use of antimicrobials) were
collected and recorded to the Case report forms. The
signs and symptoms assessed by the physician were
fever, cough, coryza, lung auscultation findings, and in-
flammation of the pharynx and the palatine tonsils.
Diagnoses were coded according to the International
Classification of Diseases 10th edition Australian Modifi-
cation (ICD-10-AM), which is used in all healthcare insti-
tutions in Lithuania as per requirement of the Ministry of
Health.
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Nasopharyngeal swabs were taken during the initial
visit using culturette with Amies (Deltalab, Spain) trans-
port medium and transported to a certified bacteriology
laboratory of Children’s Hospital, Affiliate of Vilnius
University Hospital Santariskiu Klinikos in Vilnius within
48 h from collection. Hare et al. compared several
methods for NP samples transport and found Amies
transport medium adequate for SPn detection [25]. Classic
cultural methods (cultivation in 5 % CO2, colony morph-
ology, optochin sensitivity) were used to isolate SPn from
the swabs [26, 27]. We were unable to perform neither
bile solubility, nor latex agglutination tests, however, we
believe that the small number of potentially lost positive
samples did not influence the accuracy of our results
due to the large sample size of our study [28]. Serotypes
were determined by means of latex agglutination reac-
tion using Pneumotest-Latex kit (Statens Serum Insti-
tute, Copenhagen, Denmark).
Children were followed-up either via phone call or an
additional visit during a 4 week period. The data ob-
tained during the follow-up were final determination of
diagnosis, duration of illness (recovery duration), treat-
ment with antimicrobials, and number of days absent
from DCC. Physicians were notified of the NP culture
results after the follow-up.
Data were processed with the IBM SPSS version 18.
Univariable Poisson regression with robust parameter
estimates was used to analyse the associations of SPn
colonization with sex, young siblings, clinical signs and
symptoms, recovery duration (groups of 1–2, 3–4, and
over 4 weeks; participants who failed to recover within
1–2 weeks were considered having longer recovery
duration), treatment with antimicrobials during current
disease, and particular diagnoses (URTI, bronchitis,
pneumonia, sinusitis, AOM). Multivariable Poisson re-
gression was used to assess the prevalence of SPn
colonization in different age groups (0–23, 24–47, and
48–71 months), adjusted for DCC attendance. Cross
tabulation with chi-squared test was used to assess the
following: associations of sex with SPn colonization,
longer recovery duration, and treatment with antimicro-
bials; associations of particular serotypes/serogroups with
longer recovery duration, and treatment with antimicro-
bials (compared to non-colonized cases); associations of
specific diagnoses (URTI, AOM, sinusitis, pneumonia,
bronchitis) with treatment with antimicrobials. Student’s
T test was used to compare the means of days absent from
DCC of SPn colonized participants with non-colonized.
Values of p less than 0.050 were considered statistically
significant.
Results
Population. A total of 900 children were included in our
study. There were 492 (54.7 %) male and 408 (45.3 %) fe-
male subjects. The prevalence of SPn colonization was
40.8 % (n = 367), and did not differ significantly between
female and male participants (168 of 408, 41.2 % and
199 of 492, 40.4 % respectively, p = 0.825). The specifics
of results from participating facilities are presented in
Table 1.
Age. We have selected three groups based on the age
of the participants: 1) aged less than 24 months; 2) 24
through 47; and 3) 48 through 71 months old. Preva-
lence of SPn colonization was similar among all three
groups when adjusted for DCC attendance (Table 2).
Siblings. At least one sibling under the age of 6 years
was present in the family in 334 (37.1 %) cases. The preva-
lence of SPn colonization in this group did not differ sig-
nificantly compared to children who have no siblings (145
of 334, 43.4 % vs 219 of 562, 39.0 %, p = 0.190) (Table 2).
Signs and symptoms. We evaluated if there were any
associations of fever, cough, coryza, lung auscultation
findings, and inflammation of the pharynx and the palat-
ine tonsils at the initial visit with SPn colonization. None
of the signs and symptoms was predictive of SPn
colonization (Table 2).
Recovery. Data on recovery duration was available for
827 (91.8 %) cases. Three groups based on recovery dur-
ation were distinguished: 1) subjectrecovered within one
to two weeks (shorter duration), 2) within 3 to 4 weeks
Table 1 Demographic specifics of the study population
Site Total
EDa Vilnius Kaunas Panevėžys Alytus Klaipėda
Samples, n 264 173 159 223 18 63 900
Positive samplesb, n (%) 121 (45.8) 86 (49.7) 52 (32.7) 82 (36.8) 2 (11.1) 24 (38.1) 367 (40.8)
Mean age, months (SD) 33.52 (16.45) 32.32 (16.33) 34.35 (18.84) 37.91 (17.57) 49.13 (15.37) 39.00 (18.57) 35.20 (17.45)
Males, n (%) 154 (58.3) 89 (51.5) 81 (50.9) 120 (53.8) 14 (77.8) 34 (54.0) 492 (54.7)
Females, n (%) 110 (41.7) 84 (48.5) 78 (49.1) 103 (46.2) 4 (22.2) 29 (46.0) 408 (45.3)
DCC attendance, n (%) 149 (56.7) 110 (64.7) 113 (71.1) 177 (79.4 %) 14 (87.5) 45 (73.8) 608 (67.6)
Antimicrobial use, n (%) 98 (39.2) 74 (43.3) 59 (37.3) 112 (50.2) 1 (12.5) 17 (28.8) 361 (40.1)
aED–Emergency Department of Children’s Hospital, Affiliate of Vilnius University Hospital Santariskiu Klinikos. b Positive nasopharyngeal samples for
Streptococcus pneumoniae
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(longer duration), and 3) no recovery within 4 weeks.
Significantly more children colonized with SPn had lon-
ger recovery duration (of 3 to 4 weeks) compared to the
children with negative cultures (114 of 335, 34.0 % vs 98
of 492, 19.9 % respectively, p < 0.001). There was a rela-
tively small number of subjects who did not recover
within 4 weeks and the proportions were similar in SPn
positive (8of 335, 2.4 %) and negative groups (12 of 492,
2.4 %). Serotypes 19F, 14, 6A, and serogroups 15 and 23
(non-23F serotypes) were associated with longer recov-
ery duration compared to non-colonized cases (Fig. 1).
Diagnoses. URTIs were diagnosed in 592 (65.8 %) cases
(ICD-10-AM codes J00 and J02-J06). Bronchitis, pneu-
monia, sinusitis and AOM (ICD-10-AM codes J20, J18,
J01, and H65-H66 respectively) were diagnosed in 249
(27.6 %) cases. There were 12 cases (1.3 %) with other
specified diagnoses and 47 cases (5.2 %) had no diagno-
sis specified. Significantly more URTIs were diagnosed
in the SPn-negative than in the SPn-positive group (384
of 533, 72.0 % vs 208 of 367, 56.7 % respectively, p <
0.001). The frequencies of diagnoses are presented in
Table 3.
Serotypes. The most frequent serotypes were 6B
(15.8 %, n = 58), 19F (13.9 %, n = 51), 23F (13.9 %, n =
51), 15 (10.1 %, n = 37), 14 (9.5 %, n = 35), 6A (9.3 %, n
= 34). Of the 367 SPn isolates 19 (5.2 %) were non-
typable. The largest proportions of AOM were among
the children colonized with serotypes 3, 6A, 18C, and
19F (Table 3). Non-23F serotypes were associated with
sinusitis in 30.0 % (n = 3) of cases. Pneumonia was most
frequently diagnosed in children colonized with serotype
14 (n = 5, 14.3 %).
Table 2 Prevalence of SPn colonization in relation to various factors during respiratory tract infection
Characteristic Colonized (n = 367) Non-colonized (n = 533) PR (95 % CI) P value
Age (months) a: <24c 90 158
24–47 196 222 1.050 (0.813–1.356) 0.840
48–71 75 137 0.736 (0.542–0.999) 0.049
Sex Male 199 293 0.982 (0.939–1.150) 0.824
Femalec 168 240
Siblings 145 189 1.114 (0.949–1.308) 0.187
DCC attendanceb 270 338 1.423 (1.105–1.832) 0.006
Signs and symptoms: Coryza 276 390 0.962 (0.753–1.230) 0.757
Cough 240 331 1.133 (0.884–1.452) 0.323
Fever 213 304 0.919 (0.740–1.143) 0.449
Tonsils 191 260 1.074 (0.882–1.308) 0.478
Auscultation 62 102 1.391 (0.881–2.197) 0.157
Throat 295 416 1.087 (0.693–1.704) 0.716
Recovery: 1–2 weeksc 213 382
3–4 weeks 114 98 1.502 (1.274–1.771) < 0.001
> 4 weeks 8 12 1.117 (0.646–1.932) 0.691
Antimicrobial use 204 157 1.901 (1.618–2.234) < 0.001
Diagnoses URTIc 208 384
Bronchitis 62 51 1.562 (1.279–1.907) < 0.001
Pneumonia 14 10 1.660 (1.164–2.369) 0.005
Sinusitis 23 13 1.818 (1.390–2.379) < 0.001
AOM 35 41 1.311 (1.004–1.712) 0.047
Others 5 7 1.186 (0.602–2.337) 0.622
Non-specified 20 27 1.211 (0.854–1.718) 0.283
PR (95 % CI)–prevalence ratio and 95 % confidence interval of Streptococcus pneumoniae nasopharyngeal colonization
Coryza–nasal secretion and/or nasal congestion
Fever–body temperature above 37.0 °C
Throat–signs of inflammation of the throat, including redness, oedema, and papules
Tonsils–signs of inflammation of the palatine tonsils, including redness, oedema, coating, and blisters
Auscultation–auscultation of the lungs, including signs of obstruction, rales, and crackles
aAdjusted for DCC attendance
bAdjusted for age
cRefference group for each comparison

























Recovery duration based on Streptococcus pneumoniae
serotype/serogroup
Recovered in 1-2 weeks Recovered in 3-4 weeks No recovery within 4 weeks
Fig. 1 Recovery duration based on Streptococcus pneumoniae serotype/serogroup. Only serotypes with at least 10 cases are displayed. Recovery
duration (1–2 vs 3–4 weeks vs longer than 4 weeks) for each serotype/serogroup compared with SPn-negative group (chi-squared test). 15–serogroup
15. 23–non-23F serotypes
Table 3 Frequencies of diagnoses per Streptococcus pneumoniae serotype and use of antimicrobials per diagnosis
Diagnosis, n (%) Total, n (%)
Unspecified Other AOM URTI Sinusitis Pneumonia Bronchitis
Serotype None 27 (5.1) 7 (1.3) 41 (7.7) 384 (72.0) 13 (2.4) 10 (1.9) 51 (9.6) 533 (59.2)
Othera 1 (4.0) 0 (0.0) 3 (12.0) 13 (52.0) 4 (16.0) 1 (4.0) 3 (12.0) 25 (2.7)
11 0 (0.0) 2 (11.8) 0 (0.0) 9 (52.9) 0 (0.0) 0 (0.0) 6 (35.3) 17 (1.9)
14 2 (5.7) 0 (0.0) 3 (8.6) 15 (42.9) 2 (5.7) 5 (14.3) 8 (22.9) 35 (3.8)
15b 2 (5.4) 0 (0.0) 3 (8.1) 25 (67.6) 1 (2.7) 2 (5.4) 4 (10.8) 37 (4.1)
18C 2 (18.2) 0 (0.0) 2 (18.2) 5 (45.5) 1 (9.1) 0 (0.0) 1 (9.1) 11 (1.2)
19A 1 (12.5) 1 (12.5) 0 (0.0) 4 (50.0) 1 (12.5) 0 (0.0) 1 (12.5) 8 (0.9)
19F 4 (7.8) 0 (0.0) 9 (17.6) 25 (49.0) 3 (5.9) 1 (2.0) 9 (17.6) 51 (5.6)
23c 0 (0.0) 0 (0.0) 0 (0.0) 5 (50.0) 3 (30.0) 0 (0.0) 2 (20.0) 10 (1.1)
23F 1 (2.0) 0 (0.0) 1 (2.0) 35 (68.6) 5 (9.8) 2 (3.9) 7 (13.7) 51 (5.7)
3 1 (9.1) 0 (0.0) 3 (27.3) 4 (36.4) 1 (9.1) 0 (0.0) 2 (18.2) 11 (1.2)
6A 2 (5.9) 0 (0.0) 6 (17.6) 19 (55.9) 1 (2.9) 1 (2.9) 5 (14.7) 34 (3.8)
6B 3 (5.2) 2 (3.4) 4 (6.9) 33 (56.9) 1 (1.7) 2 (3.4) 13 (22.4) 58 (6.4)
Non-typable 1 (5.2) 0 (0.0) 1 (5.3) 16 (84.2) 0 (0.0) 0 (0.0) 1 (5.2) 19 (2.1)
Total, n (%) 47 (5.2) 12 (1.3) 76 (8.4) 592 (65.8) 36 (4.0) 24 (2.7) 113 (12.6) 900 (100.0)
Antimicrobial use, n (%) 14 (29.7) 3 (25.0) 55 (72.4) 173 (29.2) 32 (88.8) 23 (95.8) 61 (12.6) 361 (40.1)
AOM acute otitis media, URTI upper respiratory tract infection
aCombined cases of SPn serotypes 4, 7, 7F, 6C, 9, 9V, 10, 12, 17, 19, 22
bSerogroup 15
cNon-23F serotypes
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Day care centre attendance. There were 608 children
who were attending DCC. The prevalence of SPn
colonization was significantly higher in children who
were attending DCC than those who were not (270 of
608, 44.4 % vs 94 of 284, 33.1 %, p = 0.001). We also
found that children with positive SPn cultures were lon-
ger absent from DCC due to the RTI. Females with posi-
tive SPn cultures were absent for 1.9 days longer (95 %
CI: 0.042–3.764, p = 0.045); males–1.0 days longer (95 %
CI: −0.937–3.052, p = 0.298); both sexes combined–
1.5 days longer (95 % CI: 0.138–2.867, p = 0.031). Chil-
dren with diagnoses other than URTI were on average
for 4 days longer absent from DCC than children diag-
nosed with URTI (95 % CI: 2.562–5.448, p < 0.001).
Antimicrobial use. There were 212 children (23.6 %)
who were treated with antimicrobials 1 to 6 months prior
the NP sample. Prevalence of SPn colonization did not dif-
fer significantly between children who were treated with
antimicrobials 1 to 6 months prior the NP sample and
children who were not (98 of 212, 46.2 % vs 249 of 628,
39.6 %, p = 0.093). Data on treatment with antimicrobials
during current illness was available for 869 patients
(96.5 %). Among these patients 335 (37.2 %) had one
course of antimicrobial treatment prescribed, and 26
(2.9 %) had two.
Significantly more subjects with SPn colonization were
treated with antimicrobials during current episode of
RTI compared to children with negative SPn cultures
(204 of 355, 57.5 % vs 157 of 514, 30.5 %, p < 0.001)
(Table 2).
Antimicrobials were similarly prescribed to female
and male participants (168 cases, 42.6 % and 188
cases, 40.4 % respectively, p = 0.512). Children with
pneumonia, sinusitis and AOM were more frequently
treated with antimicrobials than children with other
diagnoses. The rates of antimicrobial prescription for
specific diagnoses are presented in Table 3 and anti-
microbial use per specific serotypes cases is shown
in Fig. 2.
The prescribed antimicrobials were: amoxicillin (n =
122, 57.5 %), clarithromycin (n = 60, 28.3 %), phenoxy-
methylpenicillin (n = 48, 22.6 %), amoxicillin with cla-
vulanate (n = 44, 20.7 %), cefuroxime (n = 34, 16.0 %),
cefadroxil (n = 27, 12.7 %), azithromycin (n = 19, 8.9 %),
ampicillin with sulbactam (n = 10, 4.7 %), trimethoprim
with sulphamethoxazole (n = 6, 2.8 %), and erythromycin
(n = 3, 1.4 %).
Discussion
Respiratory tract infections are among the most common
reasons for children to seek medical advice and treatment
at the primary care physician. We studied the influence of
nasopharyngeal colonization with SPn on the clinical
course of RTIs. SPn nasopharyngeal colonization has im-
portant effects on the health of children and adults as it

























Use of antimicrobials based on Streptococcus pneumoniae 
serotype/serogroup
Antimicrobials not used Antimicrobials used
Fig. 2 Use of antimicrobials based on Streptococcus pneumoniae serotype/serogroup. Only serotypes with at least 10 cases are displayed.
Antimicrobial use (used vs not used) for each serotype/serogroup compared with SPn-negative group (chi-squared test). 15–serogroup 15.
23–non-23F serotypes
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known to be the causative agent of pneumonia, AOM, si-
nusitis, various URTI and invasive pneumococcal diseases,
there is little data on the influence of nasopharyngeal
colonization with SPn on the course of RTI. DCCs are the
main factor of pneumococcal transmission in a population
as extensively shown by Hoti et al. [22]. DCC attendance
predisposes children to SPn colonization which may
spread among their families and then further within the
adult population. Our results are in accordance to previ-
ous findings as we found DCC attendees having higher
prevalence of SPn colonization [22, 29]. Interestingly,
while the majority of sinusitis cases in our sample were
among DCC attendees, it was not the case for pneumonia
or AOM.
The median duration of SPn carriage is estimated to be
31 days in adults and 60.5 days in children [2]. SPn naso-
pharyngeal carriage may be asymptomatic in certain con-
ditions (such as a viral infection), however, it may facilitate
the conversion of SPn from commensal to a pathogen [2].
Consequently nasopharyngeal colonization with SPn may
lead to a more severe disease. While we could not deter-
mine the aetiology of the RTI from the data we obtained
in our study, we found that nasopharyngeal colonization
with SPn is associated with longer recovery duration in
children under 6 years old. The study conducted by Kristo
et al. in 2006 evaluated the effects of nasal colonization
with pathogenic bacteria (including SPn) on the course of
acute respiratory infections in children. Although they
used nasal middle metal specimens to identify bacteria
and studied children aged at least 6 years, their findings
show that SPn colonization during acute RTI was predict-
ive of a longer course of illness [30]. The longer disease
duration results in more days absent from DCC. Although
we found children colonized with SPn during acute RTI
being absent from DCC for longer periods than children
with negative NP cultures, the difference was of small
magnitude (average 1.5 days longer). The longer disease
duration and longer absence from DCC are likely to in-
crease caregiver’s absence from work which is a significant
burden to the families and society.
We found presence of siblings in families of our subjects
having no impact on the prevalence of SPn colonization.
However, we did not take into consideration the DCC
attendance status of older siblings, a factor found to be
significant for SPn spread to younger siblings by Otsuka et
al. [29].
Furthermore, we found SPn colonization to be associ-
ated with higher frequencies of pneumonia, sinusitis,
and AOM. These findings may imply that nasopharyn-
geal colonization with SPn predisposes children to dis-
eases such as sinusitis, pneumonia and AOM, possibly
by means of co-interaction of various potential pathogens
(both viral and bacterial) in the nasopharynx of the host
[2]. Our finding of more frequent RTI complications with
pneumonia in children with nasopharyngeal colonization
with SPn are in accordance with previous findings [31].
In our study 40.1 % of children were treated with
antimicrobials. Amoxicillin was the most commonly
prescribed antimicrobial constituting 57 % of all pre-
scriptions. In general, antimicrobials were appropriately
used with majority of cases treated with antimicrobials
being those of AOM, sinusitis and pneumonia, however, it
should always be kept in mind that high antibiotic expos-
ure is the most important cause for development of resist-
ance to antimicrobials [32].
The majority of respiratory tract infections begin with
non-specific symptoms such as fever, cough, and cor-
yza. The additional signs evaluated by the physician
(such as inflammation of the throat and palatine tonsils,
and chest auscultation) are also non-specific and were
not associated with SPn colonization in our study.
Other researchers examined various possible features to
aid in diagnosis of diseases caused by SPn: Chiappini et
al. found no associations of signs and symptoms with
aetiology of pneumonia [33], NP culture results were
not found to be predictive of AOM by Casey et al. [14],
and Shaikh et al. extensively studied the signs and
symptoms in order to differentiate sinusitis and uncom-
plicated upper respiratory infections and found only
green nasal discharge and sleep disturbances to be
associated with radiological findings consistent with
sinusitis [34]. These findings signify that the difficulties
in distinguishing bacterial from viral causes of RTI
remain high.
Vaccination with pneumococcal conjugate vaccines
(PCV) reduces colonization rates of vaccine serotypes
[35–38]. The protective effects of PCV were proven for
invasive pneumococcal disease [12], pneumonia [11],
and AOM [17, 39], while the PCV impact on sinusitis
is not clearly defined [40]. The overall need of anti-
microbial treatment is likely to be reduced with lower
frequencies of these diseases caused by SPn. The higher
rates of antimicrobial treatment for children with pneumo-
nia, and AOM, and sinusitis and difficulties in clinically
distinguishing children colonized with SPn point to the
importance of pneumococcal vaccines as a measure to
prevent diseases and sustain susceptibility of SPn to
antimicrobials.
The major limitation of our study is that we did not
test for other pathogens in the NP of our subjects, thus
we could not determine the actual cause of the RTI.
Nasopharyngeal colonization with SPn increases the risk
of developing pneumococcal disease (either primary or
as a complication of a previous RTI caused by another
pathogen) and this is the most likely reason of our find-
ings. An extended study with testing for other pathogens
in the respiratory tract is necessary to confirm this.
Another limitation is that we were unable to perform
Petraitiene et al. BMC Infectious Diseases  (2015) 15:403 Page 7 of 9
neither bile solubility nor latex-agglutination tests with
negative NP samples and thus up to 3 % of our negative
samples were potentially false-negative.
Conclusions
SPn nasopharyngeal colonization has a negative impact on
the course of respiratory tract infection, likely because of
SPn being the cause of the disease or a complicating fac-
tor. It is also associated with and may be responsible for
higher frequencies of bronchitis, pneumonia, acute otitis
media, sinusitis and the need of antimicrobial treatment.
Our results illustrate the negative impact of SPn colonisa-
tion on RTI (longer duration and absence from DCC) and
indirectly–importance of pneumococcal vaccines as a
measure to prevent SPn infection.
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